| Abstrakt: |
Objective. To investigate the potential information retrieved by ultrasound monitoring following the treatment for cervical ectropion. Method. We included in the study the ectropion cases confirmed after clinical evaluation completed with colposcopy. If suspected, lesional ectropion was confirmed by guided biopsy. The standard investigations consisted in the evaluation of day 21 progesterone, Chlamydia, Mycoplasma, Ureaplasma, HVS type II, HPV and bacterial infections assay. Progesterone treatment was prescribed, and anti-infectious specific treatment if indicated. Before and after treatment, transvaginal ultrasound evaluated the cervical linear and volumetric calculations and velocimetric measurements of uterine arteries flows on day 7, 14 and 21. Results. 105 women were evaluated between 2013-2016. We noted a moderate reduction of the ectropion area in 38.1% and a marked reduction in 55.2% of the cases. The size of the cervix and velocimetric indices of uterine arteries flows did not present signifficat variations after the ectropion treatment, indifferently the lesional or infectious initial status. Conclusion. In our study, ultrasound monitoring of the ectropion treatment did not provide valuable data regarding the cervical status evolution. [ABSTRACT FROM AUTHOR] |
